The Russell 2000 Index, which represents small-cap companies, has gained 18.75% year to date.
Keep Reading →
July 7 - Hedge Funds, News
Ten stocks stood firmer on Tuesday, defying a bloodbath in the broader market dragged by a steep technology selloff, with investors placing bets on their shares amid their rosy...
Keep Reading →
June 23 - News
On June 4, Travis Prentice, CIO at The Informed Momentum Co., appeared on a CNBC Television interview to discuss what’s happening outside of the AI trade, particularly the...
Keep Reading →
June 15 - Hedge Funds, News
Penny stocks continue to attract investors for good reason.
Keep Reading →
June 12 - Hedge Funds, News
On June 4, 2026, CNBC reported that global biopharma M&A is on track for its strongest year since the pre-pandemic peak seven years ago.
Keep Reading →
June 10 - Hedge Funds, News
Risk appetite, driven by artificial intelligence fervor, continues to drive sentiment in US equity markets.
Keep Reading →
June 5 - Hedge Funds, News
Iovance Biotherapeutics climbed by 15.57 percent on Thursday to end at $4.38 apiece after securing the conditional approval of Australia’s Therapeutic Goods Administration (...
Keep Reading →
June 4 - News
Nine stocks posted strong gains on Thursday, bucking a mixed performance in the broader market, driven by positive company-specific developments that boosted buying appetite.
Keep Reading →
June 4 - Market Movers, News
Small cap and mid cap stocks have been on a roll in the first half of the year as investors rotate away from mega cap tech stocks.
Keep Reading →
June 4 - Hedge Funds, News
The Russell 2000 index, which represents small-cap companies, has gained roughly 16.2% on a year-to-date basis.
Keep Reading →
June 4 - Hedge Funds, News
Penny stocks tend to attract attention when risk appetite improves, and smaller companies start participating in the market rally.
Keep Reading →
May 12 - Hedge Funds, News
On May 8, CNBC reported that Michael Burry has warned that the strong excitement around AI in the stock market is starting to look similar to the final stages of the dot-com bubble...
Keep Reading →
May 11 - Hedge Funds, News
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2026 Earnings Call Transcript May 7, 2026Iovance Biotherapeutics, Inc. reports earnings inline with expectations.
Keep Reading →
May 9 - News, Transcripts
A potential breakthrough in the US/Israel-Iran conflict lit fire under Wall Street on April 17.
Keep Reading →
April 21 - Hedge Funds, News
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the best stocks under $5 with huge upside potential. Chardan reiterated a Buy rating on Iovance Biotherapeutics, Inc.
Keep Reading →
April 20 - News
On April 17, Kevin Simpson, Capital Wealth Planning founder and CIO, appeared on CNBC’s ‘Closing Bell’ to talk about his view on equities, what to expect next week, and ...
Keep Reading →
April 19 - Hedge Funds, News
Analyst sentiment toward Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) remains constructive.
Keep Reading →
March 20 - News
The 2026 Iran conflict has resulted in a spike in volatility across markets, with the conflict expected to persist amid escalating geopolitical tensions. The broader investor...
Keep Reading →
March 19 - Hedge Funds, News
Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best get-rich-quick stocks to buy according to hedge funds.
Keep Reading →
March 14 - News
On March 9, Main Management CEO and Portfolio Manager Kim Arthur joined CNBC’s ‘Halftime Report’ to talk about what he’s seeing in his sector rotation fund, and whether...
Keep Reading →
March 13 - Hedge Funds, News
Iovance soared by 32.9 percent week-on-week to hit a new all-time high after an analyst doubled its price target for the stock, while investors loaded portfolios ahead of business...
Keep Reading →
March 7 - News
Ten companies capped off the trading week with strong double-digit gains, bucking a broader market bloodbath triggered by ongoing tensions in the Middle East that have sent oil...
Keep Reading →
March 7 - Market Movers, News
At intra-day trading, Iovance Biotherapeutics Inc.
Keep Reading →
March 7 - News
Ten stocks capped off Friday’s trading boasting strong gains, defying a market bloodbath, as investors took path from a flurry of strong corporate earnings and upbeat outlooks...
Keep Reading →
March 6 - Market Movers, News, Tech
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the Low Risk Penny Stocks to Buy Now.
Keep Reading →
March 6 - News
On March 4, Eddie Ghabour from Key Advisors Wealth Management appeared on a Schwab Network interview to discuss the buying opportunities in the market.
Keep Reading →
March 6 - Hedge Funds, News
Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the most promising penny stocks under $5 to buy.
Keep Reading →
February 26 - News
On February 23, Pierre Ouimet, head investment strategist at UBS Canada, joined BNN Bloomberg to discuss the markets and provide a spotlight on undervalued sectors.
Keep Reading →
February 26 - Hedge Funds, News
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q4 2025 Earnings Call Transcript February 24, 2026Iovance Biotherapeutics, Inc. beats earnings expectations.
Keep Reading →
February 25 - News, Transcripts
On February 2, Francis Gannon, co-CIO of Royce Investment Partners, joined CNBC’s “Power Lunch” to talk about the long-awaited upswing in small-cap stocks.
Keep Reading →
February 23 - Hedge Funds, News
Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best immunotherapy stocks to buy according to hedge funds.
Keep Reading →
February 19 - News
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the best high-return penny stocks to buy right now. On February 5, Iovance Biotherapeutics, Inc.
Keep Reading →
February 17 - News
Small-cap companies are in the spotlight amid market rotation away from technology heavyweights clobbered by premium valuation.
Keep Reading →
February 17 - Hedge Funds, News
Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best stocks under $3 to invest in. On January 9, Iovance Biotherapeutics Inc.
Keep Reading →
February 6 - News
In the stock market, stocks currently trading under $3 per share are typically small-cap stocks, defined as shares of publicly traded companies with a market capitalization between...
Keep Reading →
February 6 - Hedge Funds, News
We came across a bullish thesis on Iovance Biotherapeutics, Inc. (IOVA) on r/biotech_stocks by u/DebtFit2132. In this article, we will summarize the bulls’ thesis on IOVA.
Keep Reading →
January 15 - News, Stock Analysis
Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best biotech penny stocks to buy according to analysts.
Keep Reading →
December 31 - News
On December 24, Jared Holz of Mizuho joined 'Power Lunch' on CNBC to talk about how to play biotech moving into 2026.
Keep Reading →
December 29 - Hedge Funds, News
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2025 Earnings Call Transcript November 6, 2025Iovance Biotherapeutics, Inc. beats earnings expectations.
Keep Reading →
November 7 - News, Transcripts
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the best healthcare penny stocks to buy now. On September 9, at the H.C.
Keep Reading →
September 20 - News
The US healthcare sector is one of the biggest in the world, with spending expected to reach $5.3 trillion this year.
Keep Reading →
September 19 - Hedge Funds, News
The Bureau of Labor Statistics reported that only 22,000 jobs were added in August, much less than the 75,000 jobs that economists polled by Dow Jones had expected.
Keep Reading →
September 7 - Hedge Funds, News
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” second-quarter 2025 investor letter.
Keep Reading →
August 25 - Hedge Fund Investor Letters, News
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the Most Oversold Penny Stocks to Buy Now. On August 18, Iovance Biotherapeutics, Inc.
Keep Reading →
August 22 - News
On August 20, Venu Krishna, the head of US equity strategy at Barclays, joined CNBC television to discuss the probable market response to the Federal Reserve's policy signals, ...
Keep Reading →
August 21 - Hedge Funds, News
Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the most promising penny stocks under $5.
Keep Reading →
August 17 - News
On August 12, Jill Carey Hall, BofA Securities head of US small and mid-cap strategy, joined 'The Exchange' on CNBC to discuss the outlook for small caps, amidst their underperformance...
Keep Reading →
August 17 - Hedge Funds, News
Operator: Good day, and thank you for standing by. Welcome to the Iovance Biotherapeutics Second Quarter 2025 Financial Results Conference Call.
Keep Reading →
August 9 - News, Transcripts
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the penny stocks that will skyrocket. On July 15, Citizens JMP analyst Reni J.
Keep Reading →
August 1 - News
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the best biotech penny stocks to buy right now. On July 15, Goldman Sachs downgraded Iovance Biotherapeutics, Inc.
Keep Reading →
July 31 - News